Herbert Y Meltzer – Grants — Northwestern Scholars

View Scopus Profile

Phone+1 312 503 0309
Emailh-meltzernorthwesternedu

h-index
h10-index
h5-index

Research activity per year

If you made any changes in Pure these will be visible here soon.

3 Active
40 Finished

1 - 25 out of 43 results

Active

Prot #CT-155-C-002: A Multi-center, Exploratory, Single-Arm, 7-week Study to Evaluate the Feasibility and Acceptability of Treatment with CT-155 in People with Schizophrenia Experiencing Negative Symptoms
Meltzer, H. Y.
ICON Clinical Research, LLC, Click Therapeutics, Inc.
7/14/22 → 7/14/25
Project: Research project
Analysis of Apoaequorin as a Therapeutic Agent for Schizoprenia, Depression, and Cognitive Decline
Meltzer, H. Y., Huang, M. & Rajagopal, L.
CalciGenix, LLC
8/7/20 → 8/6/23
Project: Research project
Effects of a D1PAM on Novel Object Recognition, Social Interaction, Brain Neurotransmitter Release and markers for Synaptic Plasticity in Adult and Aged hD1Kl mice
Meltzer, H. Y., Huang, M. & Rajagopal, L.
Eli Lilly and Company
11/19/19 → 11/19/23
Project: Research project
Finished
Preclinical Studies of LB-102 (N-Methyl Amisulpride-R) (NMA) for Treatment of Major Depression, Bipolar Disorder, Schizophrenia, OCD and Behavioral Disturbance of Alzheimer's Disease
Meltzer, H. Y.
LB Pharmaceuticals, Inc.
12/1/20 → 11/30/21
Project: Research project
Exploring the modulation of synaptic/extrasynaptic NMDAR balance as a novel therapeutic strategy in Alzheimer's disease and other neurodegenerations
Sanz-Clemente, A. & Meltzer, H. Y.
National Institute on Aging
8/1/20 → 10/1/21
Project: Research project
Prot #IS00011961: The Mechanism Of ST100021 On Neurotransmitter Efflux Related To Psychosis
Meltzer, H. Y.
Dainippon Sumitomo Pharma Co., Ltd.
5/19/20 → 5/18/21
Project: Research project
Prot #SCZD-0001: A Pilot Study of Digital Health Technology Assessments in Schizophrenia
Meltzer, H. Y.
PRA Health Sciences, Millennium Pharmaceuticals, Inc
2/13/19 → 2/13/22
Project: Research project
Effect of AGN-241751 on cognition in mice
Meltzer, H. Y., Huang, M. & Rajagopal, L.
Allergan Sales, LLC
9/13/18 → 8/31/20
Project: Research project
Studies to Investigate the Mechanism of Action of Sunovion Compound SEP-856
Meltzer, H. Y., Huang, M. & Rajagopal, L.
Sunovion Pharmaceuticals Inc.
4/26/18 → 4/26/19
Project: Research project
Prot #SNR-05: An Adaptive, Phase II/III, Double-Blind, Randomized, Placebo-Controlled, Two-Part, Dose-Finding, Multi-Center Study of the Safety and Efficacy of NaBen® (Sodium Benzoate), a D-Amino Acid Oxidase Inhibitor, as an Add-on Therapy with Clozapine
Meltzer, H. Y. & Meriden, Z.
Amarex Clinical Research, SyneuRx International (Taiwan) Corp.
3/14/18 → 3/14/21
Project: Research project
Prot #17303A/20171271: Interventional, randomized, double-blind, active-controlled study of the efficacy of Lu AF35700 in patients with early-in-disease or late-in-disease treatment-resistant schizophrenia
Meltzer, H. Y. & Rado, J. T.
Quintiles, Inc., H. Lundbeck A/S
11/21/17 → 11/21/20
Project: Research project
Development of transdiagnostic genetic markers to predict suicide attempt
Meltzer, H. Y. & Li, J.
American Foundation for Suicide Prevention
11/1/17 → 10/31/19
Project: Research project
Prot #ACP-103-035: A 52-Week, Open-Label, Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia
Rado, J. T., Meriden, Z. & Meltzer, H. Y.
Quintiles, Inc., ACADIA Pharmaceuticals Inc.
9/12/17 → 6/30/22
Project: Research project
Prot #BIO-17-1142: Contribution of dopamine D3 receptor partial agonism of cariprazine to improve cognition and psychosis
Meltzer, H. Y. & Huang, M.
Allergan Sales, LLC
4/15/17 → 4/15/18
Project: Research project
Evaluate Pimavanserin, Risperidone or a combination of Pimavanserin and Risperidone in a treatment-resistant model of negative symptoms of schizophrenia
Meltzer, H. Y. & Rajagopal, L.
ACADIA Pharmaceuticals Inc.
2/10/17 → 2/10/20
Project: Research project
Validation of a pharmacogenomic panel predicting improvement in psychopathology to atypical antipsychotic drugs
Meltzer, H. Y. & Li, J.
Sunovion Pharmaceuticals Inc.
11/10/16 → 11/10/17
Project: Research project
Effect of valbenazine, a vesicular monoamine transporter (VMAT2) inhibitor, on neurotransmitter efflux in the medial prefrontal cortex and dorsal striatum of mice
Meltzer, H. Y. & Huang, M.
Neurocrine Biosciences, Inc.
9/26/16 → 9/26/19
Project: Research project
Rapastinel Mechanism of Action and Effects on Cognitive Function
Meltzer, H. Y., Huang, M. & Rajagopal, L.
Allergan Sales, LLC
9/1/16 → 11/22/19
Project: Research project
LiveWell: A Mobile Intervention for Bipolar Disorder
Goulding, E. H., Dopke, C. A., Kording, K. P., Kwasny, M. J., Liu, L., Meltzer, H. Y., Mohr, D. C., Dopke, C. A., Kording, K. P., Kwasny, M. J., Liu, L., Meltzer, H. Y. & Mohr, D. C.
National Institute of Mental Health
7/15/16 → 6/30/22
Project: Research project
Age-Related Histone Modification Effect on Antipsychotic Action
Dong, H., Chan, S., Csernansky, J. G., Fang, D. & Meltzer, H. Y.
National Institute of Mental Health
5/26/16 → 2/28/22
Project: Research project
Improving Outcomes in Schizophrenia Through Identification of Genetic Risk Factors
Meltzer, H. Y. & Li, J.
Clinical Reference Laboratory, Inc.
3/23/16 → 3/23/17
Project: Research project
Vortioxetine as a Potential Enhancer of Cognition in Schizophrenia
Meltzer, H. Y., Huang, M. & Rajagopal, L.
Takeda Pharmaceuticals U.S.A., Inc.
3/17/16 → 3/17/18
Project: Research project
Prot #SD-809-C-23: A Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Meltzer, H. Y.
INNO Clinical Outcomes, LLC, Auspex Pharmaceuticals, Inc.
5/18/15 → 5/18/18
Project: Research project
Testing the ability of JNJ-18038683, a selective serotonin (5-HT)7 antagonist, to improve cognition and reduce residual depressive symptoms in stable bipolar patients
Meltzer, H. Y.
Janssen Research & Development, LLC
5/13/15 → 12/31/21
Project: Research project
Prot #SD-809-C-20: AN OPEN-LABEL, LONG-TERM SAFETY STUDY OF SD-809 (DUTETRABENAZINE) FOR THE TREATMENT OF MODERATE TO SEVERE TARDIVE DYSKINESIA
Meltzer, H. Y.
INNO Clinical Outcomes, LLC, Auspex Pharmaceuticals, Inc.
3/2/15 → 12/31/20
Project: Research project